Indivior PLC (LON:INDV - Get Free Report) shares crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of GBX 770.30 ($10.45) and traded as high as GBX 853 ($11.57). Indivior shares last traded at GBX 847.27 ($11.50), with a volume of 211,940 shares.
Indivior Stock Performance
The firm has a 50 day moving average price of GBX 775.42 and a 200-day moving average price of GBX 829.51. The company has a market cap of £1.34 billion, a P/E ratio of -710.58, a P/E/G ratio of -5.57 and a beta of 0.19. The company has a debt-to-equity ratio of -170.06, a quick ratio of 1.52 and a current ratio of 0.83.
Indivior Company Profile
(
Get Free Report)
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Read More
Before you consider Indivior, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Indivior wasn't on the list.
While Indivior currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
